Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1748 of 6351
-
Botox vs. placebo: new hope for face pain sufferers?
Symptom relief Recruiting nowA randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
Phase 4 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Tailored gut bypass could curb obesity and malnutrition risks
Disease control Recruiting nowObesity is a serious health problem worldwide and can lead to many diseases such as diabetes, high blood pressure, heart disease, and sleep apnea. When lifestyle changes and medications are not enough, metabolic and bariatric surgery (MBS) is currently the most effective and long…
Sponsor: El-Sahel Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Exercise as medicine: new trial tests HIIT for mental health recovery
Symptom relief OngoingTwenty-five percent of the population worldwide will experience a severe mental illness during their lifetime (World Health Organization, 2017). These people present strong barriers to adhering to moderate and vigorous-intensity continuous training. It is fundamental to overcome …
Sponsor: University of Vic - Central University of Catalonia • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Sleeping baby MRI could unlock early cerebral palsy diagnosis
Knowledge-focused Recruiting nowBackground: Early diagnosis of cerebral palsy (CP) is crucial, enabling intervention when neuroplasticity is at its highest. Magnetic resonance imaging (MRI) plays a vital role in CP diagnosis. Currently, diagnostic MRI of newborns and infants with suspected brain damage relies h…
Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New web tool boosts heart failure care and family talks
Symptom relief CompletedThis randomized controlled trial evaluates the effectiveness of a web-based family-centered communication enhancement program ("Heart to Heart") designed for patients with heart failure, family caregivers, and cardiac nurses.
Sponsor: Ajou University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could a diabetes drug shield your brain after radiation?
Disease control Recruiting nowThis phase III trial evaluates whether patient care can be done remotely for patients having cranial (skull) radiation or who have previously had cranial radiation. In addition, this trial compares study outcomes between patients who get metformin and those who do not. Cranial ra…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug combo cuts chemo nausea in half for gynecologic cancer patients
Symptom relief CompletedTo determine the best method to prevent CINV caused by TC regimen in patients with gynecological malignant tumor. Paclitaxel-carboplatin (TC) is the most widely used regimen for gynecologic malignancies, yet chemotherapy-induced nausea and vomiting (CINV) remain common and distr…
Phase 3 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Can surgery boost Radiation's punch against gut and pancreatic tumors?
Disease control Recruiting nowThis phase IV trial evaluates how well giving standard of care (SOC) peptide receptor radionuclide therapy (PRRT) after SOC surgical removal of as much tumor as possible (debulking surgery) works in treating patients with grade 1 or 2, somatostatin receptor (SSTR) positive, gastr…
Phase 4 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Artificial intelligence could revolutionize ARDS diagnosis and treatment
Diagnosis CompletedBy using multi-center chest CT data, an intelligent assessment model for the severity of ARDS was constructed. Based on CT quantitative features and clinical characteristics, a prediction model for short-term critical events (such as mechanical ventilation decisions, prone positi…
Sponsor: Shanghai Zhongshan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Immune cells injected into brain tumors: a new hope for kids?
Disease control PausedThis phase I trial tests the safety, side effects, and best dose of ex vivo expanded natural killer cells in treating patients with cancerous (malignant) tumors affecting the upper part of the brain (supratentorial) that have come back (recurrent) or that are growing, spreading, …
Phase 1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
A Herb's bloom may calm the fear of first birth
Symptom relief CompletedThis is a study to see if the use of virgin mary herb during birth has an effect on fear, pain and duration during birth. Virgin mary herb is a dry plant and it is believed that when added to water during birth, it makes birth easier.
Sponsor: Uskudar University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Could a simple symptom check replace a grueling exercise test for kids?
Diagnosis CompletedExertional dyspnea has a significant impact on a child's daily life. Current guidelines recommend performing an exercise challenge test to confirm or rule out exercise-induced bronchoconstriction (EIB). But the test is not widely available. The objective of this research is to id…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New filter may improve survival in pneumonia-related kidney failure
Disease control Recruiting nowThe purpose of this study aimed to compare the efficacy of Oxiris (Baxter) and M100 filters on IL-6 as primary outcomes and other blood cell counts, blood biochemistry (serum urea, creatinine, potassium, sodium), inflammation indicators (CRP, PCT), as secondary outcomes and safet…
Sponsor: Mohd Zulfakar Mazlan, MBBS • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New MRI-Guided radiation aims to zap sarcomas with pinpoint accuracy
Disease control Recruiting nowRecent advances in radiation treatment have allowed for higher doses per treatment to be delivered safely. This study plans to use an MRI-guided linear accelerator to deliver the radiation treatment to ensure that the radiation dose is administered to the cancerous tumor, not the…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug AMG 732 aims to reduce eye bulging in thyroid eye disease
Disease control OngoingThe primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of this study is to investigate the efficacy of AMG 732 in participants with Thyroid Eye Disease (TED) afte…
Phase 1/2 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can lower doses of ibrutinib still control CLL? new trial aims to find out
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing of ibrutinib is either proactively reduced or reactively modified in response to adverse events (AEs).
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can pilates steady the steps of people with multiple sclerosis?
Symptom relief CompletedThis randomized controlled trial evaluated the effects of an 8-week Clinical Pilates program on balance and physical function in individuals with multiple sclerosis (MS). Participants were randomly allocated to one of three groups: Clinical Pilates, conventional exercise-based ph…
Sponsor: University of Patras • Aim: Symptom relief
Last updated Sep 10, 2026 06:00 UTC
-
New drug cocktail targets Hard-to-Treat HER2 cancers
Disease control OngoingThe purpose of this study is to determine the safety, tolerability, and recommended dose of ELVN-002 in combination with trastuzumab in participants with advanced-stage HER2-positive tumors and in combination with trastuzumab, and chemotherapy in participants with advanced-stage …
Phase 1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug combo offers hope for tough blood cancers
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, drug levels, drug efficacy and determine the recommended dose of BMS-986497 as a monotherapy, in double combination with Azacitidine and in triple combination with Azacitidine and Venetoclax in participants with rel…
Phase 1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for Hard-to-Treat leukemia? early trial launches
Disease control Recruiting nowThis is a clinical study aiming to assess pharmacokinetics, pharmacodynamics and preliminary efficacy of ZE46-0134 in patients with FLT3 and spliceosome mutated Relapsed or Refractory Acute Myeloid Leukemia
Phase 1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC